The scientific performance of Portuguese pharmaceutical industry: a bibliometric analysis

• Autor(a) principal: Martins, João Filipe dos Santos Lima Carneiro
• Data de Publicação: 2017
• Tipo de documento: Dissertação
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10071/15433
• topic: Portuguese pharmaceutical industry; Bibliometrics; Drug Research; Scientific publication; Economia da empresa; Concorrência; Indústria farmacêutica; Avaliação do desempenho; Investigação científica; Inovação; Medicamentos; Publicação periódica; Bibliometria

The premise that leads to this investigation is that Portuguese pharmaceutical industry offers new solutions and brainpower. As this sector is usually linked to innovation and scientific progress as a way to increase competitiveness we believed that Portuguese pharmaceutical industry was more than a simple production facilities. This thesis main objective is to evaluate the scientific performance based on both qualitative and quantitative measures applying bibliometric methods. Using Scopus database, we restricted the scope of analysis to articles or reviews published in peer reviewed scientific journals in the period between 2000 and 2016. This search retrieved 435 documents, from which 94% were articles and the rest 6% reviews. We were able to define some patterns of publication among the 10 Portuguese companies considered. As expected, Bial is, by far, the company with more published articles or reviews (243), followed by Bluepharma with about one third of the documents (69 – from which 80% were published after 2011). Most of the collaborations were with national universities and most of the authors were also Portuguese enhancing the focus on national brain-power. In what concerns to quantity and quality, the total publication growth between 2008-2009, 2011- 2012 and 2014-2015 outstands among the rest of the years and the increasing quality of the journals used by Bluepharma and Hovione and the consequent growing of their citation impact should be hilighted.